JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigeki Morita
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oe, M.
Right arrow Articles by Tokunaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oe, M.
Right arrow Articles by Tokunaga, K.

J Thorac Cardiovasc Surg 1996;112:462-471
© 1996 Mosby, Inc.

CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

PROTAMINE-INDUCED HYPOTENSION IN HEART OPERATIONS: APPLICATION OF THE CONCEPT OF VENTRICULAR-ARTERIAL COUPLING

Masahiro Oe, MD, Toshihide Asou, MD, Shigeki Morita, MD, Hisataka Yasui, MD, Kouichi Tokunaga, MD

From the Division of Cardiovascular Surgery, Research Institute of Angiocardiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Received for publication May 22, 1995; Revisions requested July 17, 1995; revisions received Sept. 13, 1995; Accepted for publication Oct. 30, 1995. Address for reprints: Masahiro Oe, MD, The Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807, Japan.

Abstract

Protamine sulfate often causes hypotension during heparin neutralization. The concept of ventricular-arterial coupling was applied to determine whether a negative inotropic effect or a vasodilating effect of protamine was the major contributing factor to this hypotension. Thirty-five patients who underwent cardiac operations were studied during operation by measuring instantaneous left ventricular pressure and aortic flow to examine the end-systolic pressure-volume relationship. We obtained end-systolic elastance and effective arterial elastance values in a beat-to-beat fashion with a single-beat estimation method. In 28 of the 35 patients (80%), mean arterial pressure decreased more than 10 mm Hg with protamine infusion. Parameters were compared at the following three points: before a decrease in mean arterial pressure (control), at maximally decreased mean arterial pressure (maximum), and at a middle point between control and maximum values (midpoint). At both midpoint and maximum, mean arterial pressure decreased significantly (control 79.6 ± 12.6 mm Hg, midpoint 66.5 ± 10.8 mm Hg, maximum 52.7 ± 9.9 mm Hg; p < 0.01). Similar changes were observed in effective arterial elastance (control 2.00 ± 0.75 mm Hg/ml, midpoint 1.60 ± 0.53 mm Hg/ml, maximum 1.31 ± 0.46 mm Hg/ml; p < 0.01). Although the decrease in end-systolic elastance at midpoint (control 3.08 ± 1.61 mm Hg/ml, midpoint 2.92 ± 1.68 mm Hg/ml) did not reach statistical significance, end-systolic elastance significantly decreased at maximum (2.63 ± 1.46 mm Hg/ml; p < 0.01). Continuous measurements showed that the decreases in mean arterial pressure and effective arterial elastance always preceded the depression of end-systolic elastance and that afterload reduction by vasodilating effect of protamine was the mechanism most likely to have initiated the hypotension. Delayed decrease in contractility may be ascribed to reduced coronary perfusion pressure caused by vasodilation or to a direct effect of protamine. (J THORACCARDIOVASCSURG1996;112:462-71)

Protamine sulfate has been used after cardiopulmonary bypass (CPB) to neutralize anticoagulation induced by heparin. Adverse cardiovascular effects of protamine, including hypotension, anaphylactoid reactions, and catastrophic pulmonary vasoconstriction, have been reported.Go 1 Among these responses, hypotension is frequently observed. Such hypotension during the critical postoperative period may cause detrimental hemodynamic changes if an appropriate intervention is not given. It has been suggested that this hypotension may result either from a vasodilating effect or from a negative inotropic effect of protamine. Despite the large number of studies,Go Go 2-13 it has not been clear which of the two, vasodilation or reduced contractility, contributes quantitatively more manner to hypotension.

Ventricular-arterial coupling is a concept built on the framework of the ventricular pressure-volume relationship.Go 14 This concept enables one to evaluate the specific contribution of the end-systolic properties of the ventricle and parameters of the arterial system to stroke volume (SV) and end-systolic pressure (Pes). Arterial and left ventricular Pes can be predicted from a simple equation consisting of three parameters representing preload (end-diastolic volume, Ved), afterload (effective arterial elastance, Ea), and systolic function (slope of the end-systolic pressure-volume relationship, ESPVR). Continuous assessment of the ESPVR has not been possible, however, because simultaneous measurements of both pressure and volume in various loading ventricular contractions are usually required to obtain ESPVR. To measure ESPVR continuously in the operating room, we used a method of estimating ESPVR from a single ejecting beat without measuring ventricular volume in a beat-to-beat fashion.Go Go 15,16 The purpose of this clinical study was to investigate whether a negative inotropic effect or a vasodilating effect of protamine was the major contributing factor to the hypotension. We attempted to quantify the contribution of each parameter to protamine-induced hypotension.

Methods

Patients
Thirty-five patients who underwent elective cardiac operations were studied (GoTable I). The study protocol was approved by the Human Subjects Committee of our institution. Informed consent was obtained from all patients.


View this table:
[in this window]
[in a new window]
  		Table I. Patient profile
 
Instrumentation
A radial arterial line and a central venous line were inserted. Before CPB was begun, each patient received intravenous heparin (3 mg/kg). Multidose cold (4º C) oxygenated crystalloid potassium cardioplegic solution was used for myocardial protection, as described elsewhere.Go 17 In addition, topical cooling with iced lactated Ringer's solution and moderate systemic hypothermia (28.4º ± 2.5º C) was employed. At the end of CPB, a micromanometer (model MPC-500; Millar Instruments, Inc., Houston, Texas) was inserted into the left ventricle through the roof of the left atrium or the ascending aorta. The time derivative of the left ventricular pressure signal (dP/dt) was calculated by a differentiator (model 1323; Nihon Koden, Tokyo, Japan). An appropriately sized electromagnetic flow probe (model FR series; Nihon Koden) was placed around the ascending aorta, proximal to the arterial cannulation site. The venous drainage cannula was then removed, and major bleeding from the heart and great vessels was surgically corrected. From 5 to 35 minutes (14.8 ± 9.5 minutes) after the end of CPB, when the patient was in hemodynamically stable condition, protamine sulfate (3 mg/kg) was infused from the central venous line over 3 minutes at a constant rate.

Data analysis
The electrocardiogram, arterial pressure, central venous pressure (CVP), left ventricular pressure, aortic flow, and dP/dt were displayed on an eight-channel chart recorder (Polygraph 360 system; NEC San-ei, Tokyo, Japan) and were stored on a tape (MR-30; TEAC, Tokyo, Japan). All recorded signals were appropriately calibrated and digitized off line at a sampling interval of 5 msec. The stored signals were analyzed by a program developed in our laboratory with a signal-processing computer system (7T17; NEC San-ei).

We used a method of estimating ESPVR from a single ejecting beatGo Go 15,16 to follow the serial hemodynamic changes. As shown in Fig. 1, if we obtain left ventricular peak isovolumic pressure (Pmax) from a given ejecting beat, a tangential line can be drawn from the Pmax point to the left upper corner of the left ventricular pressure-volume loop, which yields ESPVR. The slope of this line represents end-systolic elastance (Ees).Go Go 18,19 We estimated Pmax from a pressure curve during isovolumic contraction period. By means of the Gauss-Newton nonlinear least-square method, the pressure curve was fitted to the following equationGo 20:



View larger version (19K):
[in this window]
[in a new window]
  		Fig. 1. Principle used to assess Ees and Ea from a single ejecting beat. Left panel: Estimation of Pmax. The solid line shows a measured ejecting beat. The left ventricle was assumed as a linear time varying hydromotive pressure source, HMP(t). By fitting the isovolumic contraction portion of the measured left ventricular pressure (LVP) to the function described at the bottom of the figure (equation 1), estimated isovolumic LVP (dashed line) and Pmax were obtained. Right panel: Estimation of Ees and Ea. The line connecting the estimated Pmax point to the left upper corner (Pes) of the pressure-ejected volume loop that was obtained by integration of aortic flow yields the slope of ESPVR (Ees) and Ve (Ved - V0). Ea is the slope of the Pes-SV relationship.

 
HMP(t) = 1/2 · DPmax · (1 - cos {omega}t) + Ped (1)

where HMP is hydromotive pressure, which reflects the pressure wave of nonejecting beat, DPmax is maximum developed pressure, Ped is left ventricular end-diastolic pressure, {omega} is 2{pi}/T (in which T is the duration of contraction), and t is time. Originally, data from both isovolumic contraction and the relaxation phase of the ejecting beat were used.Go 20 We made the estimate with only the data of isovolumic contraction phase, however, because of the afterload dependency of pressure curve during the relaxation phase.Go 21 Once Pmax was estimated, the ESPVR line was drawn from the point of Pmax at arbitrarily set Ved to the left upper corner of the pressure-volume loop of the ejecting beat. The pressure of this left upper corner represented left ventricular Pes. The trajectory of the pressure-volume loop was obtained by plotting left ventricular pressure and the time integral of the ejected flow subtracted from Ved: Ved - flow(t)dt. Because Ved was an arbitrarily set number, we did not know the absolute value of the volume axis intercept of ESPVR line (V0). The difference between Ved and V0, however, which we term "effective end-diastolic volume," or Ve (Ved - V0), was available. Ea was calculated as Pes/SV.Go 14

Other hemodynamic parameters such as heart rate (HR; 60/cycle lengths), mean arterial pressure (MAP), Ped, cardiac index (CI; SV · HR/body surface area), and systemic vascular resistance (SVR; [MAP - CVP] · 80/cardiac output) were also determined in a beat-to-beat fashion. When we thought arterial pressure had reached a nadir, we slowly infused volume while being careful to avoid overinfusion. Comparisons of hemodynamic parameters were conducted at the following three points; just before MAP started to decrease after the infusion of protamine (control), when MAP was maximally decreased before volume loading (maximum), and at the middle between control and maximum (midpoint). At each point, the hemodynamic values of 5.4 ± 2.6 consecutive beats were averaged.

Evaluation of the effect of each parameter on hypotension
First, we analyzed relationships between percentage changes from each control value in MAP and changes in each parameter during hypotension.

Second, from the concept of ventricular-arterial coupling, the following equations were obtained (Fig. 1):

Pes = Ees · (Ves - V0) (2)

Pes = Ea · SV (3)

SV = Ved – Ves (4)

Ve = Ved – V0 (5)

where Ves is end-systolic volume. From these equations, the following equation is obtained:


With this equation, we evaluated the effect of parameters including contractility (Ees), afterload (Ea), and preload (Ve) on the degree of hypotension. The values of one parameter at midpoint and maximum were substituted in this equation, leaving the other parameters set to the control value. For example, the effect of Ees at midpoint on Pes was calculated as follows:

where Ees,Mid is a value of Ees at midpoint and Ea,Cont, Ve,Cont, and Pes,Cont are the control values of those parameters. The difference between Pes at Ees,Mid and Pes,Cont was obtained to quantify the effect of that parameter on Pes.

Compression of the femoral arteries
The results of this study in the first several patients suggested that the protamine-induced hypotension in these patients was caused mainly by the decreased afterload. We therefore presumed that protamine-induced hypotension could be reversed by increasing afterload. To increase afterload, we compressed the bilateral femoral arteries with the fists during the hypotensive period in seven patients rather than performing volume loading. Data obtained before and after compression of the femoral arteries were compared.

Statistical methods
Measured values were expressed by mean and standard deviation. A repeated-measures analysis of variance was used to examine the differences among the parameters at the three points. A p value less than 0.05 was considered to be statistically significant. If an overall difference was present, Bonferroni's adjustment was performed.Go 22 Comparisons of the data before and after compression of the femoral arteries were conducted by paired t test. Multiple linear regression (least squares) was used to correlate the changes of MAP with those of other parameters.

Results

Clinical profiles of the patients studied
GoTable I summarizes preoperative and operative profiles of the studied patients. Of 35 patients studied, 28 patients (80%) showed a decrease in MAP greater than 10 mm Hg during protamine administration. More advanced age and larger hearts were noticed in the patients without protamine-induced hypotension. In seven of 28 hypotensive patients, flow signals were not available because of electrical noise. Consequently, we analyzed a total of 21 patients who showed protamine-induced hypotension. Their body weights and body surface areas averaged 55.2 ± 8.7 kg and 1.56 ± 0.17 mGo 2, respectively.

Representative tracing of hemodynamic parameters
In each case, there was no change in hemodynamic parameters during the protamine infusion before MAP started to decrease. Representative changes of hemodynamic parameters during protamine-induced hypotension in a beat-to-beat fashion are shown in Fig. 2. In this case, initial decrease in MAP was observed at 50 seconds after protamine administration, and MAP was maximally decreased within next 20 seconds. Marked decreases in SVR and Ea were observed in association with the decrease in MAP. On the other hand, CI increased slightly. The other hemodynamic parameters were relatively unchanged.



View larger version (22K):
[in this window]
[in a new window]
  		Fig. 2. Representative changes of hemodynamic parameters during protamine-induced hypotension in a beat-to-beat fashion.

 
Changes in hemodynamic parameters during protamine-induced hypotension
The changes in hemodynamic parameters during protamine-induced hypotension are shown in Fig. 3. MAP started to decrease 81 ± 32 seconds after protamine administration was begun, and the maximum decrease in MAP occurred at 115 ± 38 seconds. A repeated-measures analysis of variance revealed significant decreases (p < 0.01) in MAP, SVR, Ea, and Ees. At both midpoint and maximum, MAP decreased significantly (control 79.6 ± 12.6 mm Hg vs midpoint 66.5 ± 10.8 mm Hg, p < 0.01; control vs maximum 52.7 ± 9.9 mm Hg, p < 0.01; and midpoint vs maximum, p < 0.01). Similar trends were observed in changes of SVR (control 1359 ± 433 dynes · sec · cm-5 vs midpoint 1050 ± 330 dynes · sec · cm-5, p < 0.01; control vs maximum 826 ± 320 dynes · sec · cm-5, p < 0.01; and midpoint vs maximum, p < 0.01) and Ea (control 2.00 ± 0.75 mm Hg/ml vs midpoint 1.60 ± 0.53 mm Hg/ml, p < 0.01; control vs maximum 1.31 ± 0.46 mm Hg/ml, p < 0.01; and midpoint vs maximum, p < 0.01). Although the slight decrease in Ees at midpoint (control 3.08 ± 1.61 mm Hg/ml vs midpoint 2.92 ± 1.68 mm Hg/ml) did not reach statistical significance, Ees decreased significantly from control (p < 0.01) and from midpoint (p < 0.01) at the maximum point (2.63 ± 1.46 mm Hg/ml). HR, CI, Ped, and Ve did not change significantly. The data regarding percentage change, Pes, dP/dt, and Ea/Ees are summarized in GoTable II.



View larger version (47K):
[in this window]
[in a new window]
  		Fig. 3. Changes of hemodynamic parameters during protamine-induced hypotension. Results are shown for each point with averaged raw data for each of the 21 patients.

 

View this table:
[in this window]
[in a new window]
  		Table II. Summary of hemodynamic parameters during protamine-induced hypotension
 
Effects of each parameter on hypotension
The percentage changes from the each control value in MAP during hypotension correlated well with changes in SVR and Ea (Fig. 4). On the other hand, there were no correlations between the percentage changes in MAP and changes in Ees and Ve.



View larger version (34K):
[in this window]
[in a new window]
  		Fig. 4. Relationships between percentage changes from each control value in MAP (%MAP) and changes in Ea (%Ea), Ees (%Ees), SVR (%SVR), or Ve (%Ve) during protamine-induced hypotension. %MAP had significant correlations with %SVR (dashed line; y = 0.55x + 36.9, r = 0.74, p < 0.001, standard error of the estimate 5.7%) and with %Ea (dashed line; y = 0.47x + 39.9, r = 0.60, p < 0.001, standard error of the estimate 7.5%). Neither %Ees nor %Ve had any significant correlation with %MAP.

 
Because Pes, as determined by single-beat estimation, was close to MAP (Pes = 0.97 MAP + 24.3, r = 0.80, p < 0.001, standard error of estimate 2.7 mm Hg), we evaluated the effect of each parameter on Pes as a substitute for MAP.Go 14 This is summarized in Fig. 5. There were negative effects on Pes in response to decreases in Ees and Ea. Potential decreases in Ees at midpoint and maximum would reduce Pes by 1.8 ± 4.4 mm Hg (not significant) and 4.5 ± 7.1 mm Hg (p < 0.01), respectively, provided there were no changes in the other parameters. Greater potential effects of Ea would be observed at both midpoint (10.0 ± 6.6 mm Hg, p < 0.01) and maximum (19.3 ± 9.9 mm Hg, p < 0.01). Because there was no significant change in Ve during hypotension, the changes in Ve did not have any significant effect on Pes.



View larger version (29K):
[in this window]
[in a new window]
  		Fig. 5. Left panel: Bar graph showing decreased MAP at midpoint and maximum during protamine-induced hypotension. Right panel: Bar graph showing effect of each parameter on the change in Pes. {Delta}Pes describes the effect of a change in a parameter on the Pes, provided that the other two parameters remain at their control values.

 
Compression of the femoral arteries
Systemic arterial pressure was increased about 10 to 20 mm Hg with compression of the femoral arteries during protamine-induced hypotension. The hemodynamic parameters before and after compression of the femoral arteries in the seven patients treated this way were summarized in GoTable III. SVR and Ea were increased significantly with compression of the femoral arteries, thereby increasing MAP significantly. HR, CI, Ped, Ve, and Ees did not change significantly.


View this table:
[in this window]
[in a new window]
  		Table III. Hemodynamic parameters before and after compression of the femoral arteries
 
Discussion

In this study, the hemodynamic changes of protamine-induced hypotension in patients who were separated from CPB occurred at 80 to 120 seconds after protamine administration at a constant rate over 180 seconds. During this period, as shown in Figs. 2 and 3, MAP, SVR, and Ea rapidly decreased, whereas the other parameters, including HR, Ped, Ve, and CI, remained relatively unchanged. Although the load-insensitive parameter of contractility, Ees, decreased significantly at the end of this period, continuous measurement of these changing parameters showed that the change in Ees was always preceded by the changes in MAP, SVR, and Ea. The concept of ventricular-arterial coupling predicts that decreases in both Ea and Ees will decrease arterial pressure. In our studies, there were greater potential effects of Ea than those of Ees, and the decrease in MAP correlated well with the decreases in SVR and Ea but not with that in Ees (Figs. 4 and 5). These results suggest that the possible mechanism by which protamine induces hypotension is afterload reduction through its vasodilatory effect.

Left ventricular ESPVR is nearly linear across the working range of the heart, and the slope of this relationship (Ees) reflects contractile state. Ees is therefore considered a load-insensitive parameter of contractility on the basis of studies with isolated heart preparations.Go 23 Analysis of left ventricular ESPVR in human beings has been hindered, however, by difficulties in simultaneous measurement of left ventricular pressure and volume under altered loading conditions. In several studies in human beings,Go Go 24-26 left ventricular volume and pressure were measured by cardiac catheterization, radionuclide angiography, or a conductance catheter. The ESPVR was constructed by altering the loading conditions, under the assumption that the contractile state was not affected by neurohumoral control mechanisms during alterations in loading, which may not actually be the case. In addition, continuous assessment of ESPVR in a beat-to-beat fashion has not been available. Moreover, these volumetric methods, with the exception of the conductance catheter, are not available in the operating room. We therefore applied the method previously used to assess Ees of the in situ canine heartGo Go 18,19 to patients who underwent heart operations. We estimated Pmax from a given ejecting beat with the curve-fitting technique (Fig. 1).Go Go Go 15,16,20 The validity of the estimate of Pmax and Ees was not tested in human beings. We did, however, examine the relationship between Ees calculated by this method and Ees measured by actual aortic crossclamping in 17 canine hearts.Go 15 The estimated and measured Pmax of 232 beats in various loading conditions were compared, and the correlation coefficient was 0.92. The estimation error of the Ees obtained by this method relative to that obtained by actual aortic crossclamping was approximately 10%. Takeuchi and coworkersGo 16 have validated independently the similar method in patients by measuring ventricular volume with angiography. We therefore considered the estimated Pmax and Ees to be acceptable. Simultaneous measurements of aortic flow and left ventricular pressure, combined with the estimation of Pmax, enabled us to assess Ees in a beat-to-beat fashion under changing hemodynamic conditions.

The concept of ventricular-arterial coupling is based on the framework of ventricular pressure-volume relationship.Go 14 This coupling was made possible by characterizing the linear functions of both the ventricle and the arterial system in terms of their Pes and SV (Pes-SV) relationships. This approach yielded Pes and SV as the intersection between the ventricular Pes-SV relationship and arterial Pes-SV relationship. Accordingly, as described in the Methods section, Pes can be predicted by a simple equation consisting of three parameters representing preload, afterload, and systolic function. From the equation, the effects of Ees and Ea on Pes are summarized as follows: (1) If Ees is equal to Ea, the changes in Ees and Ea have equivalent effect on Pes. (2) If Ees is greater than Ea, the changes in Ees have a smaller effect on Pes than do the changes in Ea. (3) If Ees is less than Ea, the changes in Ees have a larger effect on Pes than do the changes in Ea. In this study, the control value of Ea was smaller than Ees. In addition, the absolute changes in Ea were larger. The net effect of Ea on Pes was therefore larger than the effect of Ees, as shown in Fig. 5. Decreases in Ees represent depression of myocardial contractility, whereas decreases in Ea reflect more complex physiologic responses. Because Ea can be approximated by the ratio of total arterial resistance to cardiac cycle length,Go 14 relative changes in these two factors determine Ea. During protamine-induced hypotension, cardiac cycle length did not change significantly. The decreases in Ea in this study therefore represented decreases in arterial resistance.

The concept of ventricular-arterial coupling also provides information about ventricular mechanical and metabolic efficiency.Go 27 When the Ea/Ees ratio lies between 0.5 and 1.0, both mechanical and metabolic efficiencies are greater than 90% of optimal values in the analytic model. Asanoi, Sasayama, and KameyamaGo 28 suggested that the coupling was normally set toward higher metabolic efficiency (the Ea/Ees ratio toward 0.5) in human beings. In our study, despite a relatively large amount of patient-to-patient variability, the mean Ea/Ees ratio at control was 0.88 ± 0.66, and this was comparable to the values (0.90 ± 0.21) reported by Asanoi, Sasayama, and KameyamaGo 28 for patients with mild left ventricular dysfunction.

Adverse cardiovascular responses to protamine have been reported to fall into three distinct types: transient hypotension, anaphylactoid reactions, and catastrophic pulmonary vasoconstriction.Go 1 There may be complex mechanisms inducing such variable responses. Anaphylactoid reactions were not seen in the 35 patients in our study. Although not all patients had been monitored for pulmonary artery pressure, pulmonary arterial hypertension was not seen in the monitored patients and no respiratory problems were seen in the other patients. Consequently, we decided that we could analyze protamine-induced transient hypotension in our study. Because not all patients had induced hypotension (GoTable I), variability in patient response to protamine may exist. We included several different types of procedures in the study, which may have influenced the variability. With respect to the composition of the procedures, we could not include coronary artery bypass grafting because the method used for measurement requires an electromagnetic flow probe to be placed around the ascending aorta.

The mechanisms of protamine-induced hypotension have not been clearly defined.Go 1 Dose-related direct negative inotropic effects of protamine have been reported in both humanGo 7 and porcineGo 13 isolated muscle preparations. In an isolated rabbit heart preparation, protamine had dose- and time-specific adverse effects on cardiac contractility.Go 12There may be differences between findings in isolated heart preparations and those in in vivo studies, where neurohumoral reflexes can minimize protamine-induced vasodilation; effects of protamine on myocardial function were reported as positive inotropic changes,Go 9 negative inotropic changes,Go 10 or no changesGo 11 in several in vivo animal studies. As reported by Jaques,Go 8 marked variations in protamine toxicity were observed among species used for experimentation. In addition, the influence of CPB was not involved in the studies on small animals. Several authors reported that protamine in their clinical studies had certain effects on the myocardial function or the peripheral vascular beds,Go Go 2-4 whereas others reported no effects.Go Go 5,6We observed both depressed myocardial contractility and vasodilation, and we quantitatively showed the greater potential effect of vasodilation than depressed contractility. Shapira and associatesGo 3 continuously recorded the hemodynamic parameters in a human study, and their results were generally compatible with ours. Because they observed a decrease in myocardial contractility simultaneous with the decrease in blood pressure, they suggested that the depressed myocardial contractility was a direct effect of protamine. In our study, however, decreased contractility was preceded by decreases in MAP and afterload. Consequently, a delayed decrease in contractility at the end of hypotensive period seems to be ascribable to two possible mechanisms. One possible explanation is exhausted coronary autoregulatory reserve at the end of hypotension, which might be below a level of critical coronary perfusion pressure.Go 29 The other is the direct effect of protamine because the decreased contractility did not increase with the moderate increase in MAP by the femoral artery compression technique (GoTable III). The isovolumic measurements of myocardial contractile element velocity that Shapira and associatesGo 3 used as an index of contractility have been reported to lack sufficient stability during acute changes in loading conditions.Go 30 The difference in used indexes of contractility may have contributed to the difference.

Our conclusion that protamine-induced hypotension was initially caused by decreased afterload was partially verified by use of the femoral artery compression technique. As shown in GoTable III, MAP, Ea, and SVR were increased by simply compressing the bilateral femoral arteries with the fists, leaving other parameters unchanged. Several interventions against protamine-induced hypotension have been reported. Those include pretreatment with calcium chloride, infusion of inotropics, volume loading, and combinations of these interventions.Go 9 Because this hypotension is usually transient, as reported by Shapira and associates,Go 3 such interventions may not be always required. Patients with good cardiac functional reserve may tolerate this hypotensive condition, but patients with poor cardiac functional reserve may, because reduced coronary perfusion pressure impairs myocardial contractility, show further deterioration if an appropriate intervention is not performed.Go 29 Compression of the femoral arteries provided prompt recovery of MAP and thus would increase coronary perfusion pressure. Recently, we have routinely used this simple and effective method to treat protamine-induced hypotension by maintaining coronary perfusion pressure.

Certain limitations of this study should be mentioned. First, recent studies questioned the load independence and linearity of ESPVR under a variety of conditions.Go Go 31,32 Little and coworkers,Go 33 however, reported that a consistent nonlinearity present at all inotropic states did not prevent ESPVR from being well approximated by a straight line and that Ees provided a sensitive parameter of contractile state. We reported elsewhere that the average variance of the Ees measured by actual aortic crossclamping in the canine heart during volume loading within the physiologic range was small enough to be negligible.Go 19 We therefore consider ESPVR to be acceptable for measuring contractility. Second, under changing hemodynamic conditions with decreasing afterload, ejecting ventricular pressure may be modulated by a changing relationship between ventricle and arterial system. The ventricular pressure curve of relaxation phase was also reported to be dependent on afterload.Go 21 We did not use the pressure curve of the isovolumic relaxation phase, however, but instead used that of the isovolumic contraction phase in our single-beat estimation method. Accordingly, the estimated Ees would be relatively insensitive to changes in ventricular pressure during ejection and relaxation. Third, Ea was originally defined as a steady-state arterial parameter that incorporates the principal elements of vascular load.Go 14 Because of the viscoelastic properties of the arterial system, the accuracy of estimating Ea in a beat-to-beat fashion during decreasing arterial pressure is controversial. Because we adopted the measured parameters at maximum, however, when arterial pressure had reached a nadir, at least the points of control and maximum were considered to be at a steady state. Only with these two sets of data could we make the same conclusion regarding the contribution analysis in a quantitative manner (Fig. 5; control vs. maximum). Fourth, we could not analyze the data for seven of 28 hypotensive patients because of electrical noise in the flow signals. Although changing hemodynamic patterns of acquired pressure data for these seven patients were not different from those in 21 analyzed patients, it is unknown whether exclusion of 25% of the patients might have affected results and conclusions. Finally, because the volume axis intercept of the ESPVR line (V0) could not be measured by our method, we applied Ve to substitute for Ved. Even if V0 was changed during the hypotension, the ventricular Pes-SV relation and arterial Pes-SV relation merely moved parallel along the volume axis, so the change in V0 would not influence the coupling of these relations.

References

  1. Horrow CJ. Protamine: a review of its toxicity. Anesth Analg 1985;64:348-61.[Free Full Text]
  2. Jastrzebski J, Sykes MK, Woods DG. Cardiorespiratory effects of protamine after cardiopulmonary bypass in man. Thorax 1974;29:534-8.[Abstract/Free Full Text]
  3. Shapira N, Schaff HV, Piehier JM, White RD, Still JC, Pluth JR. Cardiovascular effects of protamine sulfate in man. J THORAC CARDIOVASC SURG 1982;84:505-14.[Abstract]
  4. Frater RW, Oka Y, Hong Y, Tsubo T, Loubser PG, Masone R. Protamine-induced circulatory changes. J THORAC CARDIOVASC SURG1984;87:687-92.
  5. Pauca AL, Graham JE, Hudspeth AS. Hemodynamic effects of intraaortic administration of protamine. Ann Thorac Surg 1983;35:637-42.[Abstract]
  6. Katz NM, Kim YD, Siegelman R, Ved SA, Ahmed SW, Wallace RB. Hemodynamics of protamine administration: comparison of right atrial, left atrial, and aortic injections. J THORAC CARDIOVASC SURG 1987;94:881-6.[Abstract]
  7. Hendry PJ, Taichman GC, Keon WJ. The myocardial contractile responses to protamine sulfate and heparin. Ann Thorac Surg 1987;44:263-8.[Abstract]
  8. Jaques LB. A study of the toxicity of protamine (Salmine). Br J Pharmacol 1949;4:135-44.[Medline]
  9. Gourin A, Streisand RL, Stuckey JH. Total cardiopulmonary bypass, myocardial contractility, and the administration of protamine sulfate. J THORAC CARDIOVASC SURG1971;61:160-6.
  10. Fadali MA, Papacostas CA, Duke JJ, Ledbetter M, Osbakken M. Cardiovascular depressant effect of protamine sulphate: experimental study and clinical implications. Thorax 1976;31:320-3.[Abstract/Free Full Text]
  11. Taylor RL, Little WC, Freeman GL, et al. Comparison of the cardiovascular effects of intravenous and intraaortic protamine in the conscious and anesthetized dog. Ann Thorac Surg 1986;42:22-6.[Abstract]
  12. Wakefield TW, Bies LE, Wrobleski SK, Bolling SF, Stanley JC, Kirsh MM. Impaired myocardial function and oxygen utilization due to protamine sulfate in an isolated rabbit heart preparation. Ann Surg 1990;212:387-94.[Medline]
  13. Hird RB, Spinale FG, Hewett KW, Mukherjee R, Crawford FA. The direct effect of protamine sulfate on myocyte contractile processes. J THORAC CARDIOVASC SURG1994;108:1100-14.
  14. Sunagawa K, Maughan WL, Burkoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983;245:H773-80.
  15. Asou T, Oe M, Morita S, Tanaka J, Tokunaga K, Sunagawa K. Single beat estimation of end-systolic pressure-volume relation of in situ dog heart [abstract]. Jpn Circ J 1987;51:767.
  16. Takeuchi M, Igarashi Y, Tomimoto S, et al. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 1991;83:202-12.[Abstract/Free Full Text]
  17. Kinoshita K, Oe M, Tokunaga K. Superior protective effect of low-calcium and magnesium-free potassium cardioplegic solution on ischemic myocardium; clinical study in comparison with St. Thomas' Hospital solution. J THORAC CARDIOVASC SURG 1991;101:695-702.[Abstract]
  18. Igarashi Y, Suga H. Assessment of slope of end-systolic pressure-volume line of in situ dog heart. Am J Physiol 1986;250:H685-92.
  19. Oe M, Asou T, Morita S, Fukamachi K, Mitani A, Tokunaga K. Beneficial effect of pericardial meshing on left ventricular pump performance in dogs. J THORAC CARDIOVASC SURG1991;101:260-8.
  20. Sunagawa K, Yamada A, Senda Y, Kikuchi Y, Nakamura M, Shibahara T, et al. Estimation of the hydromotive source pressure from ejecting beats of the left ventricle. IEEE Trans Biomed Eng 1980;27:299-305.[Medline]
  21. Hori M, Inoue M, Kitakaze M, Tsujioka K, Ishida Y, Fukunami M, et al. Ejection timing as a major determinant of left ventricular relaxation rate in isolated perfused canine heart. Circ Res 1984;55:31-8.[Abstract/Free Full Text]
  22. Glantz SA. Experiments when subjects are observed after many treatments; repeated-measures analysis of variance. In: Glantz SA. Primer of biostatistics. 2nd ed. New York: McGraw-Hill, 1987:265-77.
  23. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 1973;32:314-22.[Abstract/Free Full Text]
  24. Grossman W, Braunwald E, Mann T, McLaurin LP, Green LH. Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation 1977;56:845-52.[Abstract/Free Full Text]
  25. McKay RG, Aroesty JM, Heller GV, Royal HD, Warren SE, Grossman W. Assessment of the end-systolic pressure-volume relationship in human beings with the use of a time-varying elastance model. Circulation 1986;74:97-104.[Abstract/Free Full Text]
  26. Kass DA, Midei M, Graves W, Brinker JA, Maughan WL. Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 1988;15:192-202.[Medline]
  27. Burkhoff D, Sagawa K. Ventricular efficiency predicted by an analytical model. Am J Physiol 1986;250:R1021-7.[Abstract/Free Full Text]
  28. Asanoi H, Sasayama S, Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989;65:483-93.[Abstract/Free Full Text]
  29. Sunagawa K, Maughan WL, Friesinger G, Guzman P, Chang MS, Sagawa K. Effects of coronary arterial pressure on left ventricular end-systolic pressure-volume relation of isolated canine heart. Circ Res 1982;50:727-34.[Abstract/Free Full Text]
  30. Quinones MA, Gaasch WH, Alexander JK. Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation 1976;53:293-302.[Abstract/Free Full Text]
  31. Burkhoff D, Sugiura S, Yue DT, Sagawa K. Contractility dependent curvilinearity of end-systolic pressure-volume relations. Am J Physiol 1987;252:H1218-27.[Abstract/Free Full Text]
  32. Kass DA, Beyar R, Lankford E, Heard M, Maughan WL, Sagawa K. Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation 1989;79:167-78.[Abstract/Free Full Text]
  33. Little WC, Cheng CP, Peterson T, Johansen VJ. Response of the left ventricular end-systolic pressure-volume relation in conscious dogs to a wide range of contractile states. Circulation 1988;78:736-45.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. Mekkaoui, P. H. Rolland, A. Friggi, M. Rasigni, and T. G. Mesana
Pressure-flow loops and instantaneous input impedance in the thoracic aorta: Another way to assess the effect of aortic bypass graft implantation on myocardial, brain, and subdiaphragmatic perfusion
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 699 - 710.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shigeki Morita
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oe, M.
Right arrow Articles by Tokunaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oe, M.
Right arrow Articles by Tokunaga, K.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS